Irbesartan Tablet
Product Images NDC 50268-441

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 50268-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

440 15

FDA Label Image

441 15

441 15
This text appears to be a description of a medication called Irbesartan. It is available in tablet form with each tablet containing 150 mg of Irbesartan. The medication is prescription-only and comes in a unit-dose packaging of 50 tablets (5 X 10). The usual dosage and full prescribing information can be found in the package insert. The medication should be stored at a controlled room temperature of 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit).*
FDA Label Image

442 15

442 15
NDC 50268442-15 is a prescription medication called Irbesartan. It is available in the form of tablets with a strength of 300 mg. Each package contains 50 tablets, which are organized into 5 blister packs of 10 tablets each. The medication is for oral use only and should be taken as directed by a healthcare professional. The tablets contain 300 mg of Irbesartan USP. It is important to refer to the package insert for complete prescribing information and to follow the recommended dosage. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F) according to USP guidelines. This medication is manufactured for AvKare and their address is provided.*
FDA Label Image

Figure1.jpg (Figure1)

Figure1.jpg (Figure1)
The text provided seems to be a table or graph showing the cumulative event rate (%) for different treatments over a period of several months. However, due to the errors and absence of clear labels or headings, it is not possible to provide a more specific description of the data.*
FDA Label Image

Figure.jpg (Figure)

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.